Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.

Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, Malice MP, Reiss TF; Montelukast Spring Rhinitis Study Group.

Clin Exp Allergy. 2002 Jul;32(7):1020-8. Erratum in: Clin Exp Allergy. 2009 Oct;39(10):1622.

PMID:
12100048
2.

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.

van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Reiss TF; Montelukast Spring Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):214-22.

PMID:
12602669
3.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2002 Jun;88(6):592-600.

PMID:
12086367
4.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.

Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.

J Allergy Clin Immunol. 2000 May;105(5):917-22.

PMID:
10808172
5.

Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.

van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF; Montelukast Fall Rhinitis Study Group.

Allergy. 2003 Dec;58(12):1268-76. Erratum in: Allergy. 2004 Mar;59(3):357. Allergy. 2009 Nov;64(11):1697.

6.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
7.

Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.

Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett GC, Dass SB, Knorr BA, Reiss TF.

Ann Allergy Asthma Immunol. 2005 Dec;95(6):551-7.

PMID:
16400895
8.

Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.

Lu S, Malice MP, Dass SB, Reiss TF.

J Asthma. 2009 Nov;46(9):878-83. doi: 10.3109/02770900903104540.

PMID:
19905912
9.

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.

Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, Reiss TF.

Curr Med Res Opin. 2004 Oct;20(10):1549-58.

PMID:
15462688
10.

Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Nayak A, Langdon RB.

Drugs. 2007;67(6):887-901. Review.

PMID:
17428106
11.

Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.

Razi C, Bakirtas A, Harmanci K, Turktas I, Erbas D.

Ann Allergy Asthma Immunol. 2006 Dec;97(6):767-74.

PMID:
17201236
12.

Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.

Meltzer EO, Philip G, Weinstein SF, LaForce CF, Malice MP, Dass SB, Santanello NC, Reiss TF.

Am J Rhinol. 2005 Nov-Dec;19(6):591-8.

PMID:
16402647
13.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
14.

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.

Busse WW, Casale TB, Dykewicz MS, Meltzer EO, Bird SR, Hustad CM, Grant E, Zeldin RK, Edelman JM.

Ann Allergy Asthma Immunol. 2006 Jan;96(1):60-8.

PMID:
16440534
15.

Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.

Chervinsky P, Philip G, Malice MP, Bardelas J, Nayak A, Marchal JL, van Adelsberg J, Bousquet J, Tozzi CA, Reiss TF.

Ann Allergy Asthma Immunol. 2004 Mar;92(3):367-73.

PMID:
15049402
16.

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.

Ratner PH, Howland WC 3rd, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.

Ann Allergy Asthma Immunol. 2003 May;90(5):536-42.

PMID:
12775135
17.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
18.
19.
20.

Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.

Mucha SM, deTineo M, Naclerio RM, Baroody FM.

Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):164-72.

PMID:
16490874

Supplemental Content

Support Center